Early Outcomes of Thoracoscopic Anatomical Lesion Resection for Congenital Lung Malformations in Children: A Single-Center Experience in a Limited-Resource Country

September 30, 2026 updated by: Mohamed Abdelmaboud, Al-Azhar University

This study aimed to evaluate the safety and efficacy of thoracoscopic resection for CLMs in pediatric patients.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Retrospectove study of pediatric patients who underwent thoracoscopic resection for CLMs between 2023 and 2026. Demographics, clinical presentation, operative parameters, and postoperative outcomes were analyzed.

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Pediatric patients

Description

Inclusion Criteria:

  • pediatric patients underwent thoracoscopic managment of congenital lung malformations

Exclusion Criteria:

  • patients underwent open thoracotomy for congenital lung malformations
  • Recurrent cases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: RETROSPECTIVE

Cohorts and Interventions

Group / Cohort
Patients underwent thoracoscopic managment of congemital lung malformation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Conversion to open
Time Frame: One month
One month

Secondary Outcome Measures

Outcome Measure
Time Frame
Postoperative complications
Time Frame: One month
One month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Al-Azhar University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 30, 2026

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

October 30, 2026

Study Registration Dates

First Submitted

September 30, 2026

First Submitted That Met QC Criteria

September 30, 2026

First Posted (Actual)

October 6, 2026

Study Record Updates

Last Update Posted (Actual)

October 6, 2026

Last Update Submitted That Met QC Criteria

September 30, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Ped-Surg.256MedResearch

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe